{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:19:22Z","timestamp":1789471162876,"version":"build-2803163510"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>\n                    Mismatch repair deficiency (MMRD) is involved in the initiation of both hereditary and sporadic tumors. MMRD has been extensively studied in colorectal cancer and endometrial cancer, but not so in other tumors, such as ovarian carcinoma. We have determined the expression of mismatch repair proteins in a large cohort of 502 early-stage epithelial ovarian carcinoma entailing all the 5 main subtypes: high-grade serous carcinoma, endometrioid ovarian carcinoma (EOC), clear cell carcinoma (CCC), mucinous carcinoma, and low-grade serous carcinoma. We studied the association of MMRD with clinicopathologic and immunohistochemical features, including tumor-infiltrating lymphocytes in EOC, the histologic type in which MMRD is most frequent. In addition,\n                    <jats:italic toggle=\"yes\">MLH1<\/jats:italic>\n                    promoter methylation status and massive parallel sequencing were used to evaluate the proportion of sporadic and Lynch syndrome\u2013associated tumors, and the most frequently mutated genes in MMRD EOCs. MMRD occurred only in endometriosis-associated histologic types, and it was much more frequent in EOC (18%) than in CCC (2%). The most frequent immunohistochemical pattern was loss of MLH1\/PMS2, and in this group, 80% of the cases were sporadic and secondary to\n                    <jats:italic toggle=\"yes\">MLH1<\/jats:italic>\n                    promoter hypermethylation. The presence of somatic mutations in mismatch repair genes was the other mechanism of MMRD in sporadic tumors. In this series, the minimum estimated frequency of Lynch syndrome was 35% and it was due to germline mutations in\n                    <jats:italic toggle=\"yes\">MLH1<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">MSH2<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">MSH6. ARID1A<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PTEN<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">KTM2B<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                    were the most common mutated genes in this series. Interestingly, possible actionable mutations in\n                    <jats:italic toggle=\"yes\">ERRB2<\/jats:italic>\n                    were found in 5 tumors, but no\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    mutations were detected. MMRD was associated with younger age and increased tumor-infiltrating lymphocytes. Universal screening in EOC and mixed EOC\/CCC is recommended for the high frequency of MMRD detected; however, for CCC, additional clinical and pathologic criteria should be evaluated to help select cases for analysis.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001432","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T11:27:29Z","timestamp":1579174049000},"page":"649-656","source":"Crossref","is-referenced-by-count":63,"title":["Mismatch Repair Deficiency in Ovarian Carcinoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Susanna","family":"Leskela","sequence":"first","affiliation":[{"name":"Institute Ram\u00f3n y Cajal for Health Research"},{"name":"CIBER-ONC, Carlos III Health Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Romero","sequence":"additional","affiliation":[{"name":"Clinical Area of Gynecological Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Cristobal","sequence":"additional","affiliation":[{"name":"Institute Ram\u00f3n y Cajal for Health Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"P\u00e9rez-Mies","sequence":"additional","affiliation":[{"name":"CIBER-ONC, Carlos III Health Institute"},{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Rosa-Rosa","sequence":"additional","affiliation":[{"name":"Institute Ram\u00f3n y Cajal for Health Research"},{"name":"CIBER-ONC, Carlos III Health Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gutierrez-Pecharroman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Caniego-Casas","sequence":"additional","affiliation":[{"name":"Institute Ram\u00f3n y Cajal for Health Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Sant\u00f3n","sequence":"additional","affiliation":[{"name":"CIBER-ONC, Carlos III Health Institute"},{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Ojeda","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"L\u00f3pez-Reig","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Valencian Institute of Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Palacios-Berraquero","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Navarra University Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Universitari Vall d\u2019Hebron, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ibarra","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Son Ll\u00e0tzer, Palma de Mallorca"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Hakim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Miguel Servet, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Guarch","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital de Navarra, Pamplona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"L\u00f3pez-Guerrero","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Valencian Institute of Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Poveda","sequence":"additional","affiliation":[{"name":"Oncogynecologic Department, Initia Oncology, Hospital Quironsalud Valencia, Valencia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Palacios","sequence":"additional","affiliation":[{"name":"Institute Ram\u00f3n y Cajal for Health Research"},{"name":"CIBER-ONC, Carlos III Health Institute"},{"name":"Department of Pathology, Hospital Ram\u00f3n y Cajal"},{"name":"Faculty of Medicine, University of Alcal\u00e1 de Henares, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.2217\/fon-2018-0319","article-title":"Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond","volume":"14","author":"Wong","year":"2018","journal-title":"Future Oncol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10689-018-00117-1","article-title":"Recent advances in Lynch syndrome","volume":"18","author":"Biller","year":"2019","journal-title":"Fam Cancer"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/humu.23688","article-title":"EPCAM mutation update: variants associated with congenital tufting enteropathy and Lynch syndrome","volume":"40","author":"Pathak","year":"2019","journal-title":"Hum Mutat"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1308.e1","DOI":"10.1053\/j.gastro.2014.08.041","article-title":"Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations","volume":"147","author":"Haraldsdottir","year":"2014","journal-title":"Gastroenterology"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ejhg.2014.242","article-title":"Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer","volume":"23","author":"Elsayed","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ejhg.2010.216","article-title":"Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer","volume":"19","author":"Yoshida","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ejhg.2015.252","article-title":"Combined mismatch repair and POLE\/POLD1 defects explain unresolved suspected Lynch syndrome cancers","volume":"24","author":"Jansen","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach","volume":"30","author":"Luchini","year":"2019","journal-title":"Ann Oncol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2018.06.018","article-title":"Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics","volume":"80","author":"Prat","year":"2018","journal-title":"Hum Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/modpathol.2017.81","article-title":"Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups","volume":"30","author":"Parra-Herran","year":"2017","journal-title":"Mod Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-08-1387","article-title":"Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology","volume":"14","author":"Pal","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/ijc.25835","article-title":"Frequency of mismatch repair deficiency in ovarian cancer: a systematic review. This article is a US Government work and, as such, is in the public domain of the United States of America","volume":"129","author":"Murphy","year":"2011","journal-title":"Int J Cancer"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PAS.0b013e31823bc434","article-title":"Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability","volume":"36","author":"Aysal","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAS.0000000000001165","article-title":"Incidence of mismatch repair protein deficiency and associated clinicopathologic features in a cohort of 104 ovarian endometrioid carcinomas","volume":"43","author":"Bennett","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/PGP.0b013e31824fe2aa","article-title":"Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors","volume":"31","author":"Lu","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.humpath.2003.12.009","article-title":"Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma","volume":"35","author":"Cai","year":"2004","journal-title":"Hum Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygyno.2018.02.009","article-title":"Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer","volume":"149","author":"Xiao","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3892\/mco.2014.397","article-title":"Features of ovarian cancer in Lynch syndrome (review)","volume":"2","author":"Nakamura","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2015.12.005","article-title":"Ovarian cancer in Lynch syndrome; a systematic review","volume":"55","author":"Helder-Woolderink","year":"2016","journal-title":"Eur J Cancer"},{"key":"R21-20230922","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001365","article-title":"The frequency and prognostic significance of the histological type in early-stage ovarian carcinoma. A reclassification study by the Spanish Group for Ovarian Cancer Research (GEICO)","author":"Leskela","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/PGP.0000000000000274","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"Kobel","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12575-018-0084-7","article-title":"Modified SureSelect(QXT) Target Enrichment Protocol for Illumina Multiplexed Sequencing of FFPE samples","volume":"20","author":"Rosa-Rosa","year":"2018","journal-title":"Biol Proced Online"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"12742","DOI":"10.1038\/srep12742","article-title":"Performance comparison of four commercial human whole-exome capture platforms","volume":"5","author":"Shigemizu","year":"2015","journal-title":"Sci Rep"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/bioinformatics\/bts146","article-title":"CONTRA: copy number analysis for targeted resequencing","volume":"28","author":"Li","year":"2012","journal-title":"Bioinformatics"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41379-019-0302-0","article-title":"A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases","volume":"32","author":"Meagher","year":"2019","journal-title":"Mod Pathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/cancers11010074","article-title":"High frequency of ERBB2 activating mutations in invasive lobular breast carcinoma with pleomorphic features","volume":"11","author":"Rosa-Rosa","year":"2019","journal-title":"Cancers"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1158\/0008-5472.CAN-13-2319","article-title":"The structural basis of PI3K cancer mutations: from mechanism to therapy","volume":"74","author":"Liu","year":"2014","journal-title":"Cancer Res"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/his.12934","article-title":"Significant frequency of MSH2\/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas","volume":"69","author":"Rambau","year":"2016","journal-title":"Histopathology"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2019.07.012","article-title":"Molecular profiling and molecular classification of endometrioid ovarian carcinomas","volume":"154","author":"Cybulska","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PAS.0b013e31816380c4","article-title":"Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger","volume":"32","author":"Jensen","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0000000000000298","article-title":"The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy","volume":"38","author":"Chui","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1525-1438.2007.00875.x","article-title":"Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40","volume":"17","author":"Domanska","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ygyno.2011.02.010","article-title":"Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors","volume":"121","author":"Ketabi","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jamaoncol.2017.0619","article-title":"Association of mismatch repair mutation with age at cancer onset in Lynch syndrome: implications for stratified surveillance strategies","volume":"3","author":"Ryan","year":"2017","journal-title":"JAMA Oncol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/modpathol.2016.132","article-title":"Molecular genetic heterogeneity in undifferentiated endometrial carcinomas","volume":"29","author":"Rosa-Rosa","year":"2016","journal-title":"Mod Pathol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"523","DOI":"10.5858\/arpa.2017-0156-OA","article-title":"Colorectal carcinomas with isolated loss of PMS2 staining by immunohistochemistry","volume":"142","author":"Alpert","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/neuonc\/nov027","article-title":"Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis","volume":"17","author":"Erson-Omay","year":"2015","journal-title":"Neuro Oncol"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"1042.e1","DOI":"10.1016\/j.cell.2017.09.048","article-title":"Comprehensive analysis of hypermutation in human cancer","volume":"171","author":"Campbell","year":"2017","journal-title":"Cell"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/jnci\/djy067","article-title":"Molecular landscape of ERBB2\/ERBB3 mutated colorectal cancer","volume":"110","author":"Loree","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gutjnl-2014-309026","article-title":"Activating ERBB2\/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer","volume":"65","author":"Kloth","year":"2016","journal-title":"Gut"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ygyno.2013.06.019","article-title":"Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies","volume":"130","author":"Ross","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ijc.20130","article-title":"Molecular alterations associated with cyclin D1 overexpression in endometrial cancer","volume":"110","author":"Moreno-Bueno","year":"2004","journal-title":"Int J Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:52:12Z","timestamp":1695408732000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001432"}},"subtitle":["Frequency, Causes, and Consequences"],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001432","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,14]]}}}